MedPath

Early Versus Delayed Artificial Rupture of Membranes (AROM Trial)

Early Phase 1
Completed
Conditions
Induction of Labor Affected Fetus / Newborn
Interventions
Procedure: amniotomy
Device: Foley Catheter
Registration Number
NCT04496908
Lead Sponsor
Christiana Care Health Services
Brief Summary

This randomized controlled trial of consenting women undergoing induction of labor with combined combination Foley catheter and pharmacologic cervical ripening seeks to efficacy of early amniotomy.

This project will include 157 women presenting at Christiana Care Health System. Women will be included if they are at least 37 weeks gestation, have a singleton pregnancy, have intact membranes and are undergoing an induction of labor using a Foley catheter combined with either misoprostol or pitocin. Following admission, women will be randomized into either early or delayed amniotomy

Women will be randomized with equal probability to the intervention group using block randomization stratified by party.

Prior to discharge from the hospital, baseline demographic and clinical data will be obtained via chart review

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
160
Inclusion Criteria
  • ≥18 years of age
  • full term (≥37 weeks) gestations determined by routine obstetrical guidelines
  • singleton gestation in cephalic presentation
  • Both nulliparous and multiparous women
  • Intact membranes
  • Bishop score of ≤6 and cervical dilation ≤2cm
Exclusion Criteria
  • Any contraindication to a vaginal delivery or to misoprostol
  • fetal demise
  • Multifetal gestation
  • major fetal anomaly
  • prior uterine surgery, previous cesarean section
  • women with HIV, hepatitis C, hepatitis B, and women with medical conditions requiring an assisted second stage
  • Additional exclusion criteria were as follows: category 3 fetal heart rate tracing, hemolysis elevated liver enzymes and low platelets (HELLP) syndrome or eclampsia, growth restriction <10th percentile (based on Hadlock growth curves) with reversal of flow in umbilical artery Doppler studies, and growth restriction <5th percentile with elevated, absent, or reversal of flow in umbilical artery Doppler studies.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Early AmniotomyamniotomyWomen in the Early AROM group will under amniotomy one hour from Foley Catheter expulsion. Labor augmentation will continue per study protocol. Refer to Appendix A for protocol regimen.
Early AmniotomyFoley CatheterWomen in the Early AROM group will under amniotomy one hour from Foley Catheter expulsion. Labor augmentation will continue per study protocol. Refer to Appendix A for protocol regimen.
Delayed AmniotomyamniotomyWomen in the Delayed AROM group will undergo amniotomy at the discretion of the obstetrician or labor provider. No specific instructions will be given.
Delayed AmniotomyFoley CatheterWomen in the Delayed AROM group will undergo amniotomy at the discretion of the obstetrician or labor provider. No specific instructions will be given.
Early AmniotomyMisoprostolWomen in the Early AROM group will under amniotomy one hour from Foley Catheter expulsion. Labor augmentation will continue per study protocol. Refer to Appendix A for protocol regimen.
Delayed AmniotomyMisoprostolWomen in the Delayed AROM group will undergo amniotomy at the discretion of the obstetrician or labor provider. No specific instructions will be given.
Primary Outcome Measures
NameTimeMethod
time to deliveryNumber of hours from removal of Foley catheter to delivery of neonate; up to 72 hours.

time to delivery (hours) defined as time from Foley Catheter expulsion to delivery regardless of mode of delivery.

Secondary Outcome Measures
NameTimeMethod
Blood transfusionthrough study completion, an average of 1 year

binary; yes/no

Time to vaginal deliveryAt time of delivery

time to delivery (hours) defined as time from Foley Catheter expulsion to delivery

Indication for cesarean deliveryAt time of delivery

discrete

Cesarean delivery rateAt time of delivery

binary; yes/no

3rd/4th degree perineal lacerationat time of delivery

binary; yes/no

ChorioamnionitisAt time of delivery

defined by the presence of maternal fever ≥100·4°f in the presence of maternal or fetal tachycardia or fundal tenderness

Wound separation-infectionthrough study completion, an average of 1 year

binary, yes/no; defined by the need for additional wound closure or the need for antibiotics

Neonatal deaththrough study completion, an average of 1 year

binary, yes/no

Maternal length of staythrough study completion, an average of 4 days

time from admission to discharge

EndometritisFrom time of delivery to time of hospital discharge; up to 6 weeks

binary; yes/no

Trial Locations

Locations (1)

Christiana Care Health Systems

🇺🇸

Newark, Delaware, United States

© Copyright 2025. All Rights Reserved by MedPath